Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#7285
Rank
S$0.72 B
Marketcap
S$20.60
Share price
-0.33%
Change (1 day)
-48.09%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$72.09 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are S$72.09 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31S$62.78 M9.3%
2024-12-31S$57.44 M11.33%
2023-12-31S$51.6 M